Lumicera Health Services, a leading specialty pharmacy and services company, announced that EMD Serono has selected it as part of the limited specialty network for MAVENCLAD (cladribine), a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). For more information about MAVENCLAD, go to mavenclad.com

Relapsing Multiple Sclerosis, also referred to as flare-ups or exacerbations, can occur as a new symptom or a worsening of existing symptoms within patients who have MS. Relapsing MS is considered an autoimmune disease—instead of defending the body against viruses or bacteria, the immune system attacks the body itself. Symptoms can last from days to months and cause permanent damage, potentially leading to future disabilities. Access to MAVENCLAD will provide additional options for MS patients who previously had a poor response to therapy.